Despite previous studies conducted in other fields (Chen et al., 2018; Wang et al., 2020; Riddell et al., 2021), the status of registered trials of anti-PD-1/PD-L1 for NPC remains unknown. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.